Lucy Therapeutics
About:
Lucy Therapeutics develops treatments for mitochondrial diseases and neurodegenerative disorders by targeting mitochondrial proteins.
Website: https://www.lucytherapeutics.com
Twitter/X: lucytherapeutix
Top Investors: Massachusetts Life Sciences Center, Engine Ventures, The Engine, Michael J. Fox Foundation, Safar Partners
Description:
Lucy Therapeutics is a biotech company providing effective treatments for neurological diseases start with the mitochondria. The company is offering a differentiated approach to drug discovery by drugging targets associated with early disease pathogenesis. The company's approach can also be expanded to provide new options for treating similar neurologically focused diseases including Parkinson's Disease (PD) and Alzheimer's Disease (AD).
$38.5M
Cambridge, Massachusetts, United States
2017-01-01
info(AT)lucytherapeutics.com
Amy Ripka
101-250
2024-05-28
Private
© 2025 bioDAO.ai